Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × lenvatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 34 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Carcinoma, Renal Cell 20 Melanoma 10 Endometrial Neoplasms 10 Neoplasms 9 Cholangiocarcinoma 8 Liver Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Biliary Tract Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Esophageal Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡